retroChimera retrosynthesis model published in Nature, tackling drug discovery's synthesis bottleneck
marwinsegler · x · 2026-09-22
The retroChimera retrosynthesis planning model by Marwin Segler's team is out in Nature. Chemical synthesis remains a critical bottleneck in drug discovery; AI synthesis planning can propose better routes and make generative molecular design tractable.
More from Research
- HyperFrames and Google DeepMind Launch Code2Video Bench for Agentic Video Tasks — aftahi_ai · 2026-09-22
- Researcher proposes strict ICLR reforms: 3-paper cap, 10-page limit, reproducibility required — A_K_Nain · 2026-09-22
- Jev reportedly does tensor logic under the hood: differentiable IF args, no wasted gen tokens — StewartalsopIII · 2026-09-22
- Microsoft's BI-Bench: Frontier LLMs Score Under 50% on End-to-End Business Intelligence — MicrosoftResearch · 2026-09-22
- What Is RLCD? Fudan Researcher Explains the Method Behind Jev — SinclairWang1 · 2026-09-22
- Is synthetic-cell SpudCell the enabling tech for mirror life? Researchers weigh in — NikoMcCarty · 2026-09-22